Stock Information
Cullinan Therapeutics Inc (CGEM)
Ticker Symbol: CGEM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $643.91 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.6801
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -41.58%
Latest News
-
Here's What Could Help Cullinan Therapeutics (CGEM) Maintain Its Recent Price Strength
Fri, Jan 23, 2026 1:55 PM
Key Financials
Financial data not available